Advanced Enzyme Technologies (NSE:ADVENZYMES, BOM:540025) said its attributable consolidated profit fell to 376.5 million Indian rupees in the fiscal third quarter from 417.7 million rupees a year ago, according to a filing to the stock exchanges on Saturday by the enzymes and probiotics company.
Earnings per share during the quarter ended Dec 31, 2024, slipped to 3.36 rupees from 3.74 rupees a year earlier.
Revenue from operation in fiscal Q3 increased year on year to 1.69 billion rupees from 1.61 billion rupees, according to the filing.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。